TipRanks
Go Ultimate55% OFF

Genscript Biotech (GNNSF) Cash flow

Genscript Biotech Cash Flow

GNNSF's free cash flow for Q2 2026 was $9.10M. For the 2026 fiscal year, GNNSF's free cash flow was decreased by $-47.58M and operating cash flow was $56.68M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ 325.52M$ 75.65M$ -286.91M$ -120.29M$ -136.79M
$ -171.95M$ -1.46B$ -357.73M$ -443.30M$ -212.55M
$ -144.89M$ 66.52M$ 1.07B$ 419.32M$ 902.14M
$ 142.49M$ 131.99M$ 1.45B$ 1.02B$ 1.18B
$ 241.69M$ -72.27M$ -444.62M$ -336.40M$ -269.83M

Currency in USD

Genscript Biotech Cash Flow

-2B-1.5B-1B-500M0500M1B1.5B201720182019202020212022202320242025OperatingInvestingFinancing